fr   en
Clinical Studies

Browse by date
Or search by keyword
Date: 2006-02-16
Phase: III
Anouncement: Launch
Biotech: Imclone (USA)
Pharma: Merck KGaA (Germany)
Product: Erbitux® (cetuximab)
Disease: non-small-cell lung cancer
Country: international study
Other: All patients have been recruited for the Flex study which studies the first-line use of Erbitux® in non-small-cell lung cancer.